Unilateral Hemispheric Proliferation of Ivy Sign on Fluid-Attenuated Inversion Recovery Images in Moyamoya Disease Correlates Highly with Ipsilateral Hemispheric Decrease of Cerebrovascular Reserve

References

1. 1.↵
   1. Ohta T,
   2. Tanaka H,
   3. Kuroiwa T

   . Diffuse leptomeningeal enhancement, “ivy sign,” in magnetic resonance images of moyamoya disease in childhood: case report. Neurosurgery 1995;37:1009–12

   PubMedWeb of Science
2. 2.↵
   1. Maeda M,
   2. Tsuchida C

   . “Ivy sign” on fluid-attenuated inversion-recovery images in childhood Moyamoya disease. AJNR Am J Neuroradiol 1999;20:1836–38

   Abstract/FREE Full Text
3. 3.↵
   1. Houkin K,
   2. Nakayama N,
   3. Kuroda S,
   4. et al

   . Novel magnetic resonance angiography stage grading for Moyamoya disease. Cerebrovasc Dis 2005;20:347–54

   CrossRefPubMed
4. 4.↵
   1. Fukui M

   . Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘Moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997;99(Suppl 2):S238–40

   PubMedWeb of Science
5. 5.↵
   1. Yamamoto S,
   2. Watanabe M,
   3. Uematsu T,
   4. et al

   . Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. AJNR Am J Neuroradiol 2004;25:242–47

   Abstract/FREE Full Text
6. 6.↵
   1. Iida H,
   2. Itoh H,
   3. Nakazawa M,
   4. et al

   . Quantitative mapping of regional cerebral blood flow using [¹²³I]N-isopropyl-ρ-iodoamphetamine (IMP) and single photon emission computed tomography. J Nucl Med 1994;35:2019–30

   Abstract/FREE Full Text
7. 7.↵
   JET Study Group. Japanese EC-IC bypass Trial (JET study): study design and interim analysis. Surg Cereb Stroke 2002;30:97–100

   CrossRef
8. 8.↵
   1. Mizumura S,
   2. Nakagawara J,
   3. Takahashi M,
   4. et al

   . Three-dimensional display in staging hemodynamic brain ischemia for JET study: objective evaluation using SEE analysis and 3D-SSP display. Ann Nucl Med 2004;18:13–21

   CrossRefPubMed
9. 9.↵
   1. Kawamura S,
   2. Ashizaki M,
   3. Saida S,
   4. et al

   . Usefulness of rate of increase in SPECT counts in one-day method of N-isopropyl-4-iodoamphetamine [123I] SPECT studies at rest and after acetazolamide challenge using a method for estimating time-dependent distribution at rest. Ann Nucl Med 2008;22:457–63

   CrossRefPubMed
10. 10.↵
    1. Yoon HK,
    2. Shin HJ,
    3. Chang YW

    . “Ivy sign” in childhood Moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images. Radiology 2002;223:384–89

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Ikezaki K,
    2. Matsushima T,
    3. Kuwabara Y,
    4. et al

    . Cerebral circulation and oxygen metabolism in childhood Moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 1994;81:843–50

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Nakagawara J,
    2. Takeda R,
    3. Suematsu K,
    4. et al

    . Quantification of regional cerebral blood flow and vascular reserve in childhood Moyamoya disease using [123I]IMP-ARG method. Clin Neurol Neurosurg 1997;99(Suppl 2):S96–99

    PubMed
13. 13.↵
    1. Nariai T,
    2. Suzuki R,
    3. Matsushima Y,
    4. et al

    . Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia. Stroke 1994:25:1014–21

    Abstract/FREE Full Text
14. 14.↵
    1. Carusone LM,
    2. Srinivasan J,
    3. Gitelman DR,
    4. et al

    . Hemodynamic response changes in cerebrovascular disease: implications for functional MR imaging. AJNR Am J Neuroradiol 2002;23:1222–28

    Abstract/FREE Full Text
15. 15.↵
    1. Fujiwara H,
    2. Momoshima S,
    3. Kuribayashi S

    . Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in Moyamoya disease. Eur J Radiol 2005;55:224–30

    CrossRefPubMedWeb of Science